Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 4, 2009, Pages 457-467

  Yee, Chee Seng ^a   McElhone, Kathleen ^b   Teh, Lee Suan ^b   Gordon, Caroline ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL BLACKBURN HOSPITAL   (United Kingdom)

Author keywords

BILAG 2004; disease activity; Health related quality of life (HRQoL); LupusQoL; outcome measures; SLE; SLEDAI 2000; SLEQoL

Indexed keywords

ANXIETY; ATTITUDE TO ILLNESS; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ACTIVITY; EMOTIONALITY; EYE DISEASE; FAMILY LIFE; FOOD INTAKE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN RELATION; INTERPERSONAL COMMUNICATION; INTERVIEW; JOB PERFORMANCE; MEDICAL ASSESSMENT; MENTAL HEALTH; MOBILIZATION; MORBIDITY; MORTALITY; PERSONAL HYGIENE; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECREATION; REST; REVIEW; SELF CARE; SHORT FORM 36; SLEEP; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOCIAL SUPPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 67649782002     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.01.007     Document Type: Review

References (65)

1. Moss K.E., Ioannou Y., Sultan S.M., et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61 5 (2002 May) 409-413
2. Isenberg D., and Ramsey-Goldman R. Assessing patients with lupus: towards a drug responder index. Rheumatology (Oxford) 38 11 (1999 Nov) 1045-1049
3. Mukhtyar C., Boumpas D., Gordon C., et al. Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus. Ann Rheum Dis 66 5 (2007 May) 569-570
4. Liang M.H., Socher S.A., Roberts W.N., and Esdaile J.M. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 31 7 (1988 Jul) 817-825
5. Bombardier C., Gladman D.D., Urowitz M.B., et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35 6 (1992 Jun) 630-640
6. Gladman D.D., Ibanez D., and Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29 2 (2002 Feb) 288-291
7. Petri M., Kim M.Y., Kalunian K.C., et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353 24 (2005 Dec 15) 2550-2558
8. Yee C.S., Isenberg D.A., Prabu A., et al. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000. Ann Rheum Dis 67 6 (2008 Jun) 873-876
9. Symmons D.P., Coppock J.S., Bacon P.A., et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). QJM 69 259 (1988 Nov) 927-937
10. Hay E.M., Bacon P.A., Gordon C., et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 86 7 (1993 Jul) 447-458
11. Isenberg D.A., Rahman A., Allen E., et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 44 7 (2005 Jul) 902-906
12. Yee C.S., Farewell V., Isenberg D.A., et al. Revised British Isles Lupus Assessment Group 2004 index: A reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum 54 10 (2006 Sep 28) 3300-3305
13. Yee C.S., Farewell V., Isenberg D.A., et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 56 12 (2007 Dec) 4113-4119
14. Sivaraj R.R., Durrani O.M., Denniston A.K., et al. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 46 12 (2007 Dec) 1757-1762
15. Lee C.K., Ahn M.S., Lee E.Y., et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis 61 6 (2002 Jun) 547-550
16. Hallegua D.S., and Wallace D.J. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol 12 5 (2000 Sep) 379-385
17. Ferrans C.E. Definitions and conceptual models of quality of life. In: Lipscomb J., Gotay C.C., and Snyder C. (Eds). Outcome assessment in cancer. Measures, methods, and applications (2005), Cambridge University Press 14-30
18. McElhone K., Abbott J., and Teh L.S. A review of health related quality of life in systemic lupus erythematosus. Lupus 15 10 (2006) 633-643
19. Maeshima E., Maeshima S., Mizobata R., et al. Life-style activities in systemic lupus erythematosus. Clin Exp Rheumatol 25 2 (2007 Mar) 189-194
20. Bultink I.E., Turkstra F., Dijkmans B.A., and Voskuyl A.E. High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life. J Rheumatol 35 (2008) 1053-1057
21. Strand V., Aranow C., Cardiel M.H., et al. Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo. Lupus 12 9 (2003) 677-686
22. US Department of Health and Human Services. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2006 Feb.
23. Curry S.L., Levine S.B., Corty E., et al. The impact of systemic lupus erythematosus on women's sexual functioning. J Rheumatol 21 12 (1994 Dec) 2254-2260
24. Fayers P.M., and Machin D. Introduction. In: Fayers P.M., and Machin D. (Eds). Quality of Life assessment, analysis and interpretation (2000), John Wiley & Sons Ltd 3-27
25. Thumboo J., and Strand V. Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singapore 36 2 (2007 Feb) 115-122
26. Jones P.W. Quality of life measurement: the value of standardisation. Eur Respir Rev 7 42 (1997) 46-49
27. Wang C., Mayo N.E., and Fortin P.R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 28 3 (2001 Mar) 525-532
28. Costa D.D., Bernatsky S., Dritsa M., et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 53 2 (2005 Apr 15) 272-278
29. Huang H.C., Chou C.T., Lin K.C., and Chao Y.F. The relationships between disability level, health-promoting lifestyle, and quality of life in outpatients with systemic lupus erythematosus. J Nurs Res 15 1 (2007 Mar) 21-32
30. Hale E.D., Treharne G.J., Norton Y., et al. 'Concealing the evidence': the importance of appearance concerns for patients with systemic lupus erythematosus. Lupus 15 8 (2006) 532-540
31. Stamm T.A., Bauernfeind B., Coenen M., et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum 57 7 (2007 Oct 15) 1287-1295
32. Curtis J.R., Deyo R.A., and Hudson L.D. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 49 2 (1994 Feb) 162-170
33. Kuriya B., Gladman D.D., Ibanez D., and Urowitz M.B. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 59 2 (2008 Feb 15) 181-185
34. Doward L.C., McKenna S.P., Whalley D., et al. The development of the L-QoL: A quality of life instrument specific to Systemic Lupus Erythematosus. Ann Rheum Dis (2008 Apr 2)
35. Grootscholten C., Ligtenberg G., Derksen R.H., et al. Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 12 6 (2003 Sep) 635-644
36. Leong K.P., Kong K.O., Thong B.Y., et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQoL). Rheumatology (Oxford) 44 10 (2005 Oct) 1267-1276
37. Wiginton K.L. Illness representations: mapping the experience of lupus. Health Educ Behav 26 4 (1999 Aug) 443-453
38. Kong K.O., Ho H.J., Howe H.S., et al. Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese. Arthritis Rheum 57 6 (2007 Aug 15) 980-985
39. McElhone K., Abbott J., Shelmerdine J., et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 57 6 (2007 Aug 15) 972-979
40. Jolly M., Pickard A.S., Wilke C., et al. Lupus specific health outcome measure for US Patients: The LupusQoL- US Version©. Ann Rheum Dis (2009)
41. Krupp L.B., LaRocca N.G., Muir J., and Steinberg A.D. A study of fatigue in systemic lupus erythematosus. J Rheumatol 17 11 (1990 Nov) 1450-1452
42. Taylor J., Skan J., Erb N., et al. Lupus patients with fatigue-is there a link with fibromyalgia syndrome?. Rheumatology (Oxford) 39 6 (2000 Jun) 620-623
43. Omdal R., Waterloo K., Koldingsnes W., et al. Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol 30 2 (2003 Feb) 283-287
44. Wysenbeek A.J., Leibovici L., Weinberger A., and Guedj D. Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol 32 7 (1993 Jul) 633-635
45. Bruce I.N., Mak V.C., Hallett D.C., et al. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 58 6 (1999 Jun) 379-381
46. Wang B., Gladman D.D., and Urowitz M.B. Fatigue in lupus is not correlated with disease activity. J Rheumatol 25 5 (1998 May) 892-895
47. Lwin C.T., Bishay M., Platts R.G., et al. The assessment of fatigue in primary Sjogren's syndrome. Scand J Rheumatol 32 1 (2003) 33-37
48. Zonana-Nacach A., Roseman J.M., McGwin Jr. G., et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. Lupus 9 2 (2000) 101-109
49. Tayer W.G., Nicassio P.M., Weisman M.H., et al. Disease status predicts fatigue in systemic lupus erythematosus. J Rheumatol 28 9 (2001 Sep) 1999-2007
50. Seawell A.H., and Danoff-Burg S. Psychosocial research on systemic lupus erythematosus: a literature review. Lupus 13 12 (2004) 891-899
51. Stoll T., Gordon C., Seifert B., et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 24 8 (1997 Aug) 1608-1614
52. Stoll T., Stucki G., Malik J., et al. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Ann Rheum Dis 55 10 (1996 Oct) 756-760
53. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum 57 8 (2007 Dec 15) 1348-1357
54. Gordon C., and Clarke A.E. Quality of life and economic evaluation in SLE clinical trials. Lupus 8 8 (1999) 645-654
55. Karlson E.W., Liang M.H., Eaton H., et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum 50 6 (2004 Jun) 1832-1841
56. Haupt M., Millen S., Janner M., et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 64 11 (2005 Nov) 1618-1623
57. Grootscholten C., Snoek F.J., Bijl M., et al. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. J Rheumatol 34 8 (2007 Aug) 1699-1707
58. Dussan K., Magder L., Brodsky R., et al. High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures. Lupus 17 12 (2008) 1079-1085
59. Bertsias G.K., Ioannidis J.P., Boletis J., et al. Evidence for selection of end-points for clinical trials in systemic lupus erytematosus (SLE): a systematic literature review. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2008 Apr 23)
60. Gordon C., Bertsias G.K., Ioannidis J.P., et al. EULAR recommendations for points to consider in conducting clinical trials in systemic lupus erythematosus (SLE). Ann Rheum Dis (2008 Apr 3)
61. Liang M., Fortin P., Schneider M., et al. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 50 11 (2004 Nov) 3418-3426
62. Wollaston S.J., Farewell V.T., Isenberg D.A., et al. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group. J Rheumatol 31 12 (2004 Dec) 2390-2394
63. Brunner H.I., Feldman B.M., Bombardier C., and Silverman E.D. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 42 7 (1999 Jul) 1354-1360
64. Gladman D.D., Goldsmith C.H., Urowitz M.B., et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol 21 8 (1994 Aug) 1468-1471
65. Gladman D.D., Goldsmith C.H., Urowitz M.B., et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 19 4 (1992 Apr) 608-611